ID   ELOV5_RAT               Reviewed;         299 AA.
AC   Q920L7; G9BD46;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   24-JUL-2024, entry version 132.
DE   RecName: Full=Very long chain fatty acid elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE            EC=2.3.1.199 {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:22216341, ECO:0000269|PubMed:23873268};
DE   AltName: Full=3-keto acyl-CoA synthase Elovl5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=ELOVL fatty acid elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE            Short=ELOVL FA elongase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=Elongation of very long chain fatty acids protein 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=Fatty acid elongase 1;
DE            Short=rELO1;
DE   AltName: Full=Very long chain 3-ketoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
DE   AltName: Full=Very long chain 3-oxoacyl-CoA synthase 5 {ECO:0000255|HAMAP-Rule:MF_03205};
GN   Name=Elovl5 {ECO:0000255|HAMAP-Rule:MF_03205};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=12005057; DOI=10.1271/bbb.66.613;
RA   Inagaki K., Aki T., Fukuda Y., Kawamoto S., Shigeta S., Ono K., Suzuki O.;
RT   "Identification and expression of a rat fatty acid elongase involved in the
RT   biosynthesis of C18 fatty acids.";
RL   Biosci. Biotechnol. Biochem. 66:613-621(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=22216341; DOI=10.1371/journal.pone.0029662;
RA   Gregory M.K., Gibson R.A., Cook-Johnson R.J., Cleland L.G., James M.J.;
RT   "Elongase reactions as control points in long-chain polyunsaturated fatty
RT   acid synthesis.";
RL   PLoS ONE 6:E29662-E29662(2011).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND MUTAGENESIS OF SER-218; CYS-219;
RP   GLY-220; TRP-231 AND TYR-233.
RX   PubMed=23873268; DOI=10.1194/jlr.m041368;
RA   Gregory M.K., Cleland L.G., James M.J.;
RT   "Molecular basis for differential elongation of omega-3 docosapentaenoic
RT   acid by the rat Elovl5 and Elovl2.";
RL   J. Lipid Res. 54:2851-2857(2013).
CC   -!- FUNCTION: Catalyzes the first and rate-limiting reaction of the four
CC       reactions that constitute the long-chain fatty acids elongation cycle.
CC       This endoplasmic reticulum-bound enzymatic process allows the addition
CC       of 2 carbons to the chain of long- and very long-chain fatty acids
CC       (VLCFAs) per cycle. Condensing enzyme that acts specifically toward
CC       polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6)
CC       acyl-CoA. May participate in the production of monounsaturated and of
CC       polyunsaturated VLCFAs of different chain lengths that are involved in
CC       multiple biological processes as precursors of membrane lipids and
CC       lipid mediators (By similarity) (PubMed:22216341, PubMed:23873268). In
CC       conditions where the essential linoleic and alpha linoleic fatty acids
CC       are lacking it is also involved in the synthesis of Mead acid from
CC       oleic acid (By similarity). {ECO:0000250|UniProtKB:Q8BHI7,
CC       ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:22216341,
CC       ECO:0000269|PubMed:23873268}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a very-long-chain acyl-CoA + H(+) + malonyl-CoA = a very-long-
CC         chain 3-oxoacyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:32727,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:90725, ChEBI:CHEBI:90736;
CC         EC=2.3.1.199; Evidence={ECO:0000255|HAMAP-Rule:MF_03205,
CC         ECO:0000269|PubMed:22216341, ECO:0000269|PubMed:23873268};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32728;
CC         Evidence={ECO:0000305|PubMed:22216341};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6Z,9Z,12Z,15Z)-octadecatetraenoyl-CoA + H(+) + malonyl-CoA =
CC         (8Z,11Z,14Z,17Z)-3-oxoicosatetraenoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:35391, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:71489,
CC         ChEBI:CHEBI:71491; Evidence={ECO:0000269|PubMed:22216341};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35392;
CC         Evidence={ECO:0000305|PubMed:22216341};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6Z,9Z,12Z)-octadecatrienoyl-CoA + H(+) + malonyl-CoA =
CC         (8Z,11Z,14Z)-3-oxoeicosatrienoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:35379, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57363, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:71481; Evidence={ECO:0000269|PubMed:22216341};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35380;
CC         Evidence={ECO:0000305|PubMed:22216341};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl-CoA + H(+) + malonyl-CoA
CC         = (7Z,10Z,13Z,16Z,19Z)-3-oxodocosapentaenoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36483, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:73862,
CC         ChEBI:CHEBI:73863; Evidence={ECO:0000269|PubMed:22216341,
CC         ECO:0000269|PubMed:23873268};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36484;
CC         Evidence={ECO:0000305|PubMed:22216341};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + H(+) + malonyl-CoA =
CC         (7Z,10Z,13Z,16Z)-3-oxodocosatetraenoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36475, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:73852; Evidence={ECO:0000269|PubMed:22216341};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36476;
CC         Evidence={ECO:0000305|PubMed:22216341};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z,15Z)-octadecatrienoyl-CoA + H(+) + malonyl-CoA =
CC         (11Z,14Z,17Z)-3-oxoeicosatrienoyl-CoA + CO2 + CoA;
CC         Xref=Rhea:RHEA:36523, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:74034,
CC         ChEBI:CHEBI:74054; Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36524;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-hexadecenoyl-CoA + H(+) + malonyl-CoA = 3-oxo-(11Z)-
CC         octadecenoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:39675,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:61540, ChEBI:CHEBI:76555;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39676;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + H(+) + malonyl-CoA = (11Z)-3-
CC         oxoicosenoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:36511,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57384, ChEBI:CHEBI:57387, ChEBI:CHEBI:74011;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36512;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(11Z)-octadecenoyl-CoA + H(+) + malonyl-CoA = 3-oxo-(13Z)-
CC         eicosenoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:39679, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57384,
CC         ChEBI:CHEBI:75121, ChEBI:CHEBI:76559;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39680;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z,12Z)-octadecadienoyl-CoA + H(+) + malonyl-CoA = (11Z,14Z)-
CC         3-oxoicosa-11,14-dienoyl-CoA + CO2 + CoA; Xref=Rhea:RHEA:36503,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57383, ChEBI:CHEBI:57384, ChEBI:CHEBI:74012;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36504;
CC         Evidence={ECO:0000250|UniProtKB:Q9NYP7};
CC   -!- PATHWAY: Lipid metabolism; polyunsaturated fatty acid biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_03205, ECO:0000269|PubMed:22216341,
CC       ECO:0000269|PubMed:23873268}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000255|HAMAP-Rule:MF_03205}; Multi-pass membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_03205}. Cell projection, dendrite
CC       {ECO:0000255|HAMAP-Rule:MF_03205}. Note=In Purkinje cells, the protein
CC       localizes to the soma and proximal portion of the dendritic tree.
CC       {ECO:0000255|HAMAP-Rule:MF_03205}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung and brain.
CC       {ECO:0000269|PubMed:12005057}.
CC   -!- SIMILARITY: Belongs to the ELO family. ELOVL5 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03205}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB071985; BAB69887.1; -; mRNA.
DR   EMBL; HQ404314; ADP36858.1; -; mRNA.
DR   RefSeq; NP_599209.1; NM_134382.1.
DR   RefSeq; XP_006243479.1; XM_006243417.2.
DR   AlphaFoldDB; Q920L7; -.
DR   SMR; Q920L7; -.
DR   STRING; 10116.ENSRNOP00000010409; -.
DR   SwissLipids; SLP:000000274; -.
DR   SwissLipids; SLP:000000452; -.
DR   PhosphoSitePlus; Q920L7; -.
DR   PaxDb; 10116-ENSRNOP00000010409; -.
DR   Ensembl; ENSRNOT00000010409.5; ENSRNOP00000010409.3; ENSRNOG00000006331.5.
DR   GeneID; 171400; -.
DR   KEGG; rno:171400; -.
DR   UCSC; RGD:620583; rat.
DR   AGR; RGD:620583; -.
DR   CTD; 60481; -.
DR   RGD; 620583; Elovl5.
DR   eggNOG; KOG3071; Eukaryota.
DR   GeneTree; ENSGT01050000244838; -.
DR   HOGENOM; CLU_048483_0_1_1; -.
DR   InParanoid; Q920L7; -.
DR   OrthoDB; 168669at2759; -.
DR   PhylomeDB; Q920L7; -.
DR   TreeFam; TF323454; -.
DR   Reactome; R-RNO-2046105; Linoleic acid (LA) metabolism.
DR   Reactome; R-RNO-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-RNO-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00658; -.
DR   PRO; PR:Q920L7; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000006331; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0097447; C:dendritic tree; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0009922; F:fatty acid elongase activity; IDA:UniProtKB.
DR   GO; GO:0034625; P:fatty acid elongation, monounsaturated fatty acid; ISS:UniProtKB.
DR   GO; GO:0034626; P:fatty acid elongation, polyunsaturated fatty acid; IDA:UniProtKB.
DR   GO; GO:0019367; P:fatty acid elongation, saturated fatty acid; IBA:GO_Central.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IDA:UniProtKB.
DR   HAMAP; MF_03205; VLCF_elongase_5; 1.
DR   InterPro; IPR002076; ELO_fam.
DR   InterPro; IPR033677; ELOVL5.
DR   PANTHER; PTHR11157:SF18; ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 5; 1.
DR   PANTHER; PTHR11157; FATTY ACID ACYL TRANSFERASE-RELATED; 1.
DR   Pfam; PF01151; ELO; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell projection; Endoplasmic reticulum;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..299
FT                   /note="Very long chain fatty acid elongase 5"
FT                   /id="PRO_0000282842"
FT   TRANSMEM        26..46
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        64..84
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        112..132
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        139..158
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        168..187
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        205..225
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   TRANSMEM        227..247
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03205"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYP7"
FT   MUTAGEN         218
FT                   /note="S->L: No effect on fatty acid elongase activity."
FT                   /evidence="ECO:0000269|PubMed:23873268"
FT   MUTAGEN         219
FT                   /note="C->S: No effect on fatty acid elongase activity."
FT                   /evidence="ECO:0000269|PubMed:23873268"
FT   MUTAGEN         220
FT                   /note="G->A: No effect on fatty acid elongase activity."
FT                   /evidence="ECO:0000269|PubMed:23873268"
FT   MUTAGEN         231
FT                   /note="W->C: Changed substrate specificity. Can elongate
FT                   (7Z,10Z,13Z,16Z,19Z)-3-oxodocosapentaenoyl-CoA into
FT                   (9Z,12Z,15Z,18Z,21Z)-3-oxotetracosapentaenoyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:23873268"
FT   MUTAGEN         233
FT                   /note="Y->I: No effect on fatty acid elongase activity."
FT                   /evidence="ECO:0000269|PubMed:23873268"
FT   CONFLICT        59
FT                   /note="F -> S (in Ref. 2; ADP36858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        64
FT                   /note="I -> T (in Ref. 2; ADP36858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        104
FT                   /note="E -> G (in Ref. 2; ADP36858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        130
FT                   /note="F -> L (in Ref. 2; ADP36858)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   299 AA;  35235 MW;  661CFAD9E168D7A8 CRC64;
     MEHFDASLST YFRALLGPRD TRVKGWFLLD NYIPTFVCSA IYLLIVWLGP KYMKNRQPFS
     CRGILVVYNL GLTLLSLYMF YELVTGVWEG KYNFFCQGTR SAGESDMKVI RVLWWYYFSK
     LIEFMDTFFF ILRKNNHQIT VLHVYHHATM LNIWWFVMNW VPCGHSYFGA TLNSFIHVLM
     YSYYGLSSVP SMRPYLWWKK YITQGQLVQF VLTIIQTSCG VIWPCSFPLG WLYFQIGYMI
     SLIALFTNFY IQTYNKKGAS RRKEHLKGHQ NGSMTAVNGH TNNFASLENS VTSRKQRKD
//
